Instem Announces Acquisition of The Edge; Extends Reach within Discovery R&D
Instem’s Acquisition of Discovery Technology Solutions Provider, The Edge, Represents Another Advancement of its Mission in the Life Sciences
PHILADELPHIA--(BUSINESS WIRE)--Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that it has acquired The Edge Software Consultancy Ltd. (“The Edge”) as part of its mission to enable clients to bring their life enhancing products to market faster. The further consolidation of key application areas will help customers streamline and accelerate their research and development processes, while access to a broader range of data from across the R&D continuum will increase the power of future in silico modelling and prediction solutions.
The Edge offers technology and services to improve the efficiency of drug discovery research and development, improving client productivity while ensuring that critical high-quality data from studies and experiments are efficiently captured, stored and shared, maximizing their value to organizations around the world.
Formed in 2005 and headquartered in Guildford, United Kingdom, The Edge’s flagship BioRails® platform enables automated high-quality data capture over the entire drug discovery and development process. The Edge are Pharmaceutical domain experts, especially in the areas of drug metabolism and pharmacokinetics, in vitro & in vivo Pharmacology and Formulations, and their platform incorporates a broad range of software modules which can be deployed individually or as a suite, either in isolation or across an enterprise.
Designed by scientists for scientists, The Edge technology solutions offer a perfect blend of Laboratory Information Management Systems, Electronic Lab Notebooks and data analytics in one seamless workflow. The Edge are well known for offering the perfect blend of IT and science to keep their clients productive as they look to identify and advance drug candidates in the journey towards clinical trials.
Since their founding, The Edge have captured the attention of many of the world’s most influential pharmaceutical, biotechnology, biopharmaceutical and contract research organizations. They have cemented strong collaborative relationships with their clients by helping them to eliminate bottlenecks, increase innovation and more cost effectively reduce their times to market.
“The go-to partner for many of our Instem clients looking to revolutionize their R&D processes, we couldn’t be happier to welcome The Edge into the Instem family,” comments Gregor Grant, Executive Vice President of Instem’s Study Management Solutions group. “We have been very interested in strengthening our position within Discovery to help us meet growing interest for the wider sharing of data. Clients of The Edge that are using our Provantis® software suite for preclinical safety assessment study management, for example, will certainly benefit by being better aligned and ultimately interconnected. The Edge are very well versed in helping clients bring together data from disparate sources, which is a complete fit into our overall mission in the life sciences.”
Grant continued, “The Edge have established an excellent delivery reputation and their products are pivotal systems trusted by biologists and chemists alike to help them collaborate using insights from safe, centrally stored data. They excel in translating their scientific credentials into tangible technology-driven benefits, and along with their excellent support model, are fully aligned with our commitment to deliver an exceptional client experience.”
Instem sees the acquisition of The Edge as an integral part of its transformational growth strategy, enabling it to further deliver solutions that meet the rapidly expanding needs of life science organizations for faster data-driven decision making, leading to safer, more effective products.
“Combining our story with a well-established and proven life science leader like Instem further validates our entire approach in the market and offers new and exciting opportunities for our clients and staff,” states Andrew Lemon, Managing Director at The Edge. “Our missions are nearly identical, and our customers are the real winners here. Harnessing the global resources, processes and reach of Instem will give us exactly what we need to take the next step in our journey to bring our innovative solutions to more scientists around the world.”
More about The Edge Solutions, now part of Instem
The Edge helps create new and efficient processes for capturing and analyzing data in the laboratory that can easily be distributed across scientific teams. Through highly-refined, automated data capture software, clients are able to reduce cycle times by establishing reliable scientific workflows which enables them to execute tests more quickly and efficiently.
BioRails is a multi-tiered platform for workflow-driven data management, which can be deployed on-premise or via SaaS, offering the following modules:
- BioHub™ – A single consolidated store for corporate knowledge that acts as a central location for all of a client’s research data
- BioRails DM™ – A comprehensive approach to study definition, data collection, analysis and data management
- BioRails PTO™ – Study project planning, tracking, ordering and optimization
- BioRails INV™ – Study inventory management, ordering and tracking
- BioRails MT™ – Materials registration for biospecimens, biologics and formulations
Morphit provides powerful features for reading, managing and visualizing data. Clients are able to uniquely and seamlessly analyze biological data from instruments and transform raw data into validated results. The capabilities of Morphit empower clients to gather extensive knowledge about experiments, which in turn refines subsequent tests for greater success.
A global provider of leading software solutions and scientific insight services, Instem is helping clients bring their life enhancing products to market faster. From Concepts to Cures, we enable organizations in the life sciences to more efficiently collect, report and submit high quality regulatory data, while offering them the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Every day, across the entire drug development value chain, Instem solutions are meeting the rapidly expanding needs of life science organizations for data-driven decision making, leading to safer, more effective products.
Instem supports its global roster of clients through offices in the United States, United Kingdom, France, Japan, China, and India.
Gary Mitchell, VP Corporate Marketing
Tel: +1 610.941.0990
Christine Duncan, Marketing Manager, Study Management Solutions
Tel: +1 610.941.0990